Alterations of EDEM1 functions enhance ATF6 pro-survival signaling

Archive ouverte

Papaioannou, Alexandra | Higa, Arisa | Jegou, Gwenaele | Jouan, Florence | Pineau, Raphael | Saas, Laure | Avril, Tony | Pluquet, Olivier | Chevet, Eric

Edité par CCSD ; Wiley -

International audience. Activating transcription factor 6 alpha (referred to as ATF6 hereafter) is an endoplasmic reticulum (ER)-resident glycoprotein and one of the three sensors of the unfolded protein response (UPR). Upon ER stress, ATF6 is exported to the Golgi complex where it is cleaved by the S1P and S2P proteases thus releasing ATF6 cytosolic fragment and leading to the transcription of ATF6 target genes. In this study, we performed a phenotypic small-interfering RNA (siRNA) screening to better characterize the ER mechanisms involved in ATF6 activation upon ER stress. This revealed that silencing of ER-degradation-enhancing alpha-mannosidase-like protein-1 (EDEM1) increased the bioavailability of ER stress-induced ATF6 export to the Golgi complex through the stabilization of the natively unstable ATF6 protein. Moreover, we characterized a somatic variant of EDEM1 (N198I) found in hepatocellular carcinoma that alters ATF6 signaling and might provide a selective advantage to the transforming cells. Hence, our work confirms the natively unstable nature of ATF6 and links this property to potentially associated pro-oncogenic functions.

Suggestions

Du même auteur

Dual IRE1 RNase functions dictate glioblastoma development

Archive ouverte | Lhomond, Stéphanie | CCSD

International audience. Proteostasis imbalance is emerging as a major hallmark of cancer, driving tumor aggressiveness. Evidence suggests that the endoplasmic reticulum (ER), a major site for protein folding and qua...

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma

Archive ouverte | Avril, Tony | CCSD

International audience. Purpose: CD90 (Thy-1) is a glycophosphatidylinositol-anchored glycoprotein considered as a surrogate marker for a variety of stem cells, including glioblastoma (GBM) stem cells (GSC). However...

Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo

Archive ouverte | Le Reste, Pierre Jean | CCSD

International audience. Glioblastoma multiforme (GBM) is the most severe primary brain cancer. Despite an aggressive treatment comprising surgical resection and radio/chemotherapy, patient's survival post diagnosis ...

Chargement des enrichissements...